Clinical Trials Browser

Phase 2 × Interventional × Dimethyl Sulfoxide × Clear all

NCT03716583 2021-09-10

MELADERM

Phase 2 Completed

Breast Neoplasms, Radiodermatitis

NCT02519816 2019-08-14

CARE

Phase 2 Unknown

Immune System Diseases